ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum
This article has 6 authors:Reviewed by ScreenIT
-
Placental vascular remodeling in pregnant women with COVID-19
This article has 8 authors:Reviewed by ScreenIT
-
Uptake of SARS-CoV-2 workplace testing programs, March 2020 to March 2021
This article has 9 authors:Reviewed by ScreenIT
-
The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa
This article has 7 authors:Reviewed by ScreenIT
-
Neuropsychiatric disorders as risk factors and consequences of COVID-19: A Mendelian randomization study
This article has 6 authors:Reviewed by ScreenIT
-
BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 Patients
This article has 8 authors:Reviewed by ScreenIT
-
National survey of attitudes towards and intentions to vaccinate against COVID-19: implications for communications
This article has 10 authors:Reviewed by ScreenIT
-
Predictors of Depression and Anxiety Symptoms in Brazil during COVID-19
This article has 6 authors:Reviewed by ScreenIT
-
Reverse-Transcription Loop-Mediated Isothermal Amplification Has High Accuracy for Detecting Severe Acute Respiratory Syndrome Coronavirus 2 in Saliva and Nasopharyngeal/Oropharyngeal Swabs from Asymptomatic and Symptomatic Individuals
This article has 50 authors:Reviewed by ScreenIT
-
PERFORMANCE AND UTILITY OF AN ORAL FLUID-BASED RAPID POINT-OF-CARE TEST FOR SARS-COV-2 ANTIBODY RESPONSE FOLLOWING COVID-19 INFECTION OR VACCINATION
This article has 6 authors:Reviewed by ScreenIT